Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-28T00:07:37.470Z Has data issue: false hasContentIssue false

Nitinol stents in the treatment of benign proximal tracheal stenosis or tracheomalacia

Published online by Cambridge University Press:  25 November 2005

A Y Isa
Affiliation:
Department of Otolaryngology, Head and Neck Surgery, Stobhill Hospital, Glasgow, UK
C Macandie
Affiliation:
Department of Otolaryngology, Head and Neck Surgery, Stobhill Hospital, Glasgow, UK
B W Irvine
Affiliation:
Department of Otolaryngology, Head and Neck Surgery, Stobhill Hospital, Glasgow, UK

Abstract

Nitinol stents have been used in the treatment of benign tracheal stenosis. A retrospective review of five patients treated at Stobhill Hospital over the last six and a half years is presented. Age at presentation ranged from 17 to 76 years. The minimum follow-up period was 23 months and the maximum was 78 months. All our patients were successfully decannulated, with none requiring recannulation. Four patients developed granulation tissue related to the stent at intervals ranging from three weeks to 41 months post stenting. Topical mitomycin C application has been useful after resection of granulations using the carbon dioxide (CO2) laser. Stent migration occurred in one patient three weeks after insertion. Nitinol stents are easy to insert and effective in the treatment of tracheal stenosis, but can have associated morbidity. Their use should be considered carefully, as insertion should be regarded as permanent. Publications reporting experience and outcome with the use of Nitinol stents in the trachea are reviewed.

Type
Main Articles
Copyright
2005 JLO (1984) Limited

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)